Member Info for stanleyb

Labour is looking after Working People, High Inflation risen every month for past 6 months, tens of thousands of job losses in hospitality industry due higher National Insurance, Highest UK borrowing rate in 50 years causing mortgage rates to rise, Council tax rises above inflation causing hardship to millions of working, households, Energy costs rising again, food inflation highest since Covid...but Kier Starmer's Labour Party looking after Working People... 😳

Not sure what on earth you are expecting seeing as the half year results were already published on the 6th August 2025..... Following disposal of Claremont for £103 million in cash..no changes from AGM statement and big reduction in debt down to £230 million..

Update on H1 2025 financial performance and H1 2025 financial highlights. Group revenue performance in line with AGM statement guidance.

H1 2025 adjusted EBITDA of c.£24m[3] (H1 2024: £37.1m), primarily reflecting substantially higher whey pricing YoY in Nutrition. Whey commodity prices have remained stable at record highs during the last 12 months, with strong global demand matching new supply capacity, leading to market wide nutrition consumer price increases.

Cash and available facilities of c.£278m[4], following the Q1 2025 refinancing which substantially reduced gross debt.

Net debt of c.£330m (H1 2024: £350m), before the net proceeds from the disposal of Claremont for £103 million (proforma c.£230m). The second half of the year remains the seasonally strong cash generative period.

Labour will not build 1 5 million homes! They are on course to Bankrupt the UK as warned by the BOE. INEOS announced yesterday they are stopping all North Sea O&G investment and spending £3 billion in USA O&G as a direct result of Lord Milliband's Carbon ban policies. It seems as if Lord Milliband is working directly for Russia and China in trying to destroy the UK O&G industry. JAO Adyor 🙄

One other point to note, once the net debt is eliminated, considering all of THG's losses were seemingly transferred to the demerged Ingenuity division, it means THG RemainCo will be able to pay dividends, probably next year as set out in the demerger statement..

JAO Adyor

THG on course to eliminate debt through its debt reduction programme...Debt reduced by 60% in past 12 months despite loans renegotiated until the end of 2029..Current rate of debt reduction there will possibly be no debt by the end of next year, also capex reduction of nearly 90% post demerger as stated, down from £110 million per annum down to circa £20 million...despite persistently high Whey Protein prices. Following demerger of Ingenuity division, THG Capex and Debt reduction together are saving THG RemainCo about £125 million this year alone!

As stated by THG recently........Specifically, capital expenditure will reduce to c. £20m pa (FY 2024 pre Demerger guidance: £100m to £110m) and cash lease costs will reduce to c. £22m pa. Future cash generation will facilitate a measured reduction in gross and net leverage, with RemainCo targeting continued progression to a neutral net cash / net debt position.

· The cash proceeds of £103 million from Claremont disposal will contribute towards reducing net leverage and borrowing costs in line with THG's capital allocation strategy targeting a neutral net cash / net debt position....

Adyor!!

The half year results were already published on the 6th August 2025..... Following disposal of Claremont for £103 million in cash..no changes from AGM statement and big reduction in debt down to £230 million..

Update on H1 2025 financial performance and H1 2025 financial highlights. Group revenue performance in line with AGM statement guidance.

H1 2025 adjusted EBITDA of c.£24m[3] (H1 2024: £37.1m), primarily reflecting substantially higher whey pricing YoY in Nutrition. Whey commodity prices have remained stable at record highs during the last 12 months, with strong global demand matching new supply capacity, leading to market wide nutrition consumer price increases.

Cash and available facilities of c.£278m[4], following the Q1 2025 refinancing which substantially reduced gross debt.

Net debt of c.£330m (H1 2024: £350m), before net proceeds from the disposal of Claremont (proforma c.£230m). The second half of the year remains the seasonally strong cash generative period.

Strategic update, H2 2025 and FY 2026

Given whey price stability, rising nutrition consumer prices and Myprotein's structurally advantaged business model, THG Nutrition delivered double-digit revenue growth across June and July combined. Between +10% and +12% revenue growth is now expected in H2 for THG Nutrition.

Whilst H2 gross margins are in solid growth vs H1 2025, to prioritise long-term market share gains and customer loyalty, Myprotein will limit price increases in H2 2025, enabling further acceleration of its installed base in global offline retail from c.34,000 doors today, towards a target of 100,000.

This opportunistic pricing approach is in line with prior discussions with shareholders and will underpin market share growth and operating leverage for the full financial year 2026.

This customer-first strategic initiative will be supported by investment of approximately £15m during 2025, and will result in a Group adjusted EBITDA of c.£50m for H2. The financial impact of this investment strategy is limited to FY 2025, with FY 2026 solely adjusting for Claremont.

H2 has also started well for THG Beauty, with an improved revenue growth rate.

Matthew Moulding, CEO of THG commented:

Claremont has been a huge success, building Myprotein's global licensing franchise from a standing start to partnering with category leading brands in just a few years.

"After receiving a highly competitive offer, the timing was right to realise that value. The level of interest we received is a testament to the quality of the business.

"This disposal highlights the significant value embedded across THG's portfolio. My sincere thanks go to the entire Claremont team for their fantastic contribution and hard work.

"Finally, the decisions we are taking as a business to support our customers and grow Myprotein's market share aligns clearly with our wider strategy to streamline the Group and focus on our core strengths, whilst maintaining a strong

Warpaint and APN overvalued but THG undervalued considering THG just sold a tiny 2% contributing non core business unit for 30% of its total market cap.

Applied Nutrition and Warpaint Cosmetics both increasing sales and maintaining much higher profit margins than THG despite THG having 10 times the sales of both companies combined 😳. High Whey prices just a distraction it seems from the THG CEO's incompetence?

https://www.lse.co.uk/rns/interim-results-h5m9qww1ep6qfvr.html

PS.. but you still won't be able to get an appointment with your GP..

The UK has enough Farmland to build at least another 200 million homes increasing the population to about 500 million people..we will have a GDP the size of the USA so can then just import all of our food from Europe, USA, Brazil, Australia, New Zealand , Canada and the Commonwealth. Job done.

RE PROXY..you and others are deliberately not taking into account the interest savings on huge debt reduction programme...debt reduced by 60% in past 12 months despite loans renegotiated until the end of 2029..So at current rate of debt reduction there will possibly be no debt by the end of next year, also capex reduction of nearly 90% post demerger as stated,down from £110 million per annum down to circa £20 million...despite persistently high Whey Protein prices, the Capex and Debt reduction together are saving THG RemainCo about £125 million this year alone!

As stated by THG recently........Specifically, capital expenditure will reduce to c. £20m pa (FY 2024 pre Demerger guidance: £100m to £110m) and cash lease costs will reduce to c. £22m pa. Future cash generation will facilitate a measured reduction in gross and net leverage, with RemainCo targeting continued progression to a neutral net cash / net debt position.

· The cash proceeds from Claremont disposal will contribute towards reducing net leverage and borrowing costs in line with THG's capital allocation strategy targeting a neutral net cash / net debt position....

Adyor!!

Post a demerger, the Group would consist of THG Beauty and THG Nutrition, two globally leading consumer businesses, which are highly profitable, cash generative and capable of paying dividends...."

Last Paragraph...

https://www.lse.co.uk/rns/escc-transfer-ingenuity-demerger-update-11s0rr0th1uzg9o.html

The small shorts position remaining can just be hedges against long positions...

One assumes that THG will quickly follow through on the debt reduction plan with other non core disposal..the partially refurbished hotel could be worth £50 million.. (that's what was paid for it in 2020)..the company could quickly find itself in a net cash position and able to pay dividends in 2026 as per previous company statements..JAO Adyor

😆 🤣 😂 just send all complaints to the CEO ..

Are you guys not capable of reading an RNS...not sure what you expect to change from the 6th August statement and half year results summary apart from a load of accountants figures, which have already been summarised on the 6th August along with the second half guidance figures...!!! 🙄

The half year results were already published on the 6th August 2025..... Following disposal of Claremont for £103 million in cash..no changes from AGM statement and big reduction in debt down to £230 million..

Update on H1 2025 financial performance and H1 2025 financial highlights

Group revenue performance in line with AGM statement guidance.

H1 2025 adjusted EBITDA of c.£24m[3] (H1 2024: £37.1m), primarily reflecting substantially higher whey pricing YoY in Nutrition. Whey commodity prices have remained stable at record highs during the last 12 months, with strong global demand matching new supply capacity, leading to market wide nutrition consumer price increases.

Cash and available facilities of c.£278m[4], following the Q1 2025 refinancing which substantially reduced gross debt.

Net debt of c.£330m (H1 2024: £350m), before net proceeds from the disposal of Claremont (proforma c.£230m). The second half of the year remains the seasonally strong cash generative period.

Strategic update, H2 2025 and FY 2026

Given whey price stability, rising nutrition consumer prices and Myprotein's structurally advantaged business model, THG Nutrition delivered double-digit revenue growth across June and July combined. Between +10% and +12% revenue growth is now expected in H2 for THG Nutrition.

Whilst H2 gross margins are in solid growth vs H1 2025, to prioritise long-term market share gains and customer loyalty, Myprotein will limit price increases in H2 2025, enabling further acceleration of its installed base in global offline retail from c.34,000 doors today, towards a target of 100,000.

This opportunistic pricing approach is in line with prior discussions with shareholders and will underpin market share growth and operating leverage for the full financial year 2026.

This customer-first strategic initiative will be supported by investment of approximately £15m during 2025, and will result in a Group adjusted EBITDA of c.£50m for H2. The financial impact of this investment strategy is limited to FY 2025, with FY 2026 solely adjusting for Claremont.

H2 has also started well for THG Beauty, with an improved revenue growth rate.

Matthew Moulding, CEO of THG commented:

Claremont has been a huge success, building Myprotein's global licensing franchise from a standing start to partnering with category leading brands in just a few years.

"After receiving a highly competitive offer, the timing was right to realise that value. The level of interest we received is a testament to the quality of the business.

"This disposal highlights the significant value embedded across THG's portfolio. My sincere thanks go to the entire Claremont team for their fantastic contribution and hard work.

"Finally, the decisions we are taking as a business to support our customers and grow Myprotein's market share aligns clearly with our wider strategy to streamline the Group and focus on our core strengths, whilst maintaining a stron

@ HappyInvesting...Yes, clearly an example of fraud in most peoples eyes.m?? Just take all the losses with Ingenuity despite the fact that Nutrition and Beauty divisions paid £1 billion for the capital expenditure to fund Ingenuity. Who paid for the Hotels and leisure club 🤔? Well obviously THG RemainCo shareholders. No corporate ethics just clever accounting from a fraudster masquerading as a CEO so it seems? JAO Adyor 🙄

Most people might call it fraud, but it was called a demerger including free hotels, sports and leisure club, City AM and the kitchen sinks....??? Oh, and no debt with a big pile of cash thrown in for good measure, but no conflicts of interest? JAO Adyor

Can I borrow your crystal ball please